Test Makers Again Question FDA Authority Over Workplace Drug Testing
This article was originally published in The Gray Sheet
Executive Summary
On-site testing manufacturers say FDA is once again overstepping its bounds in exercising regulatory authority for drug screening tests used in the workplace and other non-medical settings
You may also be interested in...
FDA Lacks Authority to Regulate Drug Abuse Tests in Workplace - NOTA
FDA does not have jurisdiction to regulate over-the-counter (OTC) drugs of abuse tests intended for use in insurance and other "non-diagnostic" settings because they are not intended to treat a medical condition, according to the National On-site Testing Association.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.